Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

8 results about "Lung abscess" patented technology

Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities (more than 2 cm) containing necrotic debris or fluid caused by microbial infection. This pus-filled cavity is often caused by aspiration, which may occur during anesthesia, sedation, or unconsciousness from injury. Alcoholism is the most common condition predisposing to lung abscesses.

Therapeutic agent for inhalation pneumonia, pulmonary suppuration or pulmonary abscess

The invention relates to a therapeutic agent for inhalation pneumonia, pulmonary suppuration or pulmonary abscess. [Problem] The present invention relates to a safer and more effective therapeutic agent for respiratory tract infections. [Solution] A therapeutic agent for inhalation pneumonia, pulmonary suppuration or pulmonary abscess, said agent containing, as an active ingredient, 7-[(3S, 4S)-3-{(cyclopropylamino) methyl}-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
Owner:KYORIN PHARMACEUTICAL CO LTD

Traditional Chinese medicine formula with functions of relieving cough and reducing sputum as well as preparation method and application of traditional Chinese medicine formula

The invention discloses a traditional Chinese medicine formula with functions of relieving cough and reducing sputum as well as a preparation method and application of the traditional Chinese medicine formula. The traditional Chinese medicine formula comprises the following traditional Chinese medicine components: radix asteris, flos farfarae, rhizoma pinellinae praeparata, perilla frutescens, herba epimedii, radix rehmanniae preparata, cudweed herb, herba ardisiae japonicae, wedelia chinensis and ginseng. Through different preparation methods, the traditional Chinese medicines can be prepared into different dosage forms such as traditional Chinese medicine cigarettes, traditional Chinese medicine oral liquid, traditional Chinese medicine concentrated pills and traditional Chinese medicine tablets so as to meet the requirements of different patients. Compared with the prior art, the traditional Chinese medicine formula disclosed by the invention is prepared from natural traditional Chinese medicines, has no obvious side effect and is safe and reliable to a human body. The traditional Chinese medicine composition has obvious cough-relieving and sputum-reducing effects, especially has obvious cough-relieving and sputum-reducing effects on cough and excessive sputum caused by cold, cough and asthma, bronchitis, pneumonia, lung abscess, white lung, long-term smoking and deficiency of lung, spleen and kidney, and can be used for removing sputum, including pus sputum, old sputum and viscous sputum, accumulated in lung bronchus. The traditional Chinese medicine has effects on old and new coughs, wind cold, wind heat and rheumatic coughs.
Owner:戴政德

External antipyretic pharmaceutical composition as well as preparation method and application thereof

The invention provides an external antipyretic pharmaceutical composition as well as a preparation method and application thereof. The composition consists of radix bupleuri, mint, gypsum, raw ephedra, elsholtzia, scutellaria baicalensis, isatis root and rhizoma smilacis glabrae. The preparation method comprises the following steps: mixing the eight medicinal materials, adding water, decocting, and sub-packaging the decoction into bags. Clinical tests prove that the buyi foot bath antipyretic prescription prepared by the invention can effectively improve clinical symptoms such as cough, lung signs, yellow and greasy tongue coating, slippery pulse, dry mouth and throat and the like of a child patient, can effectively reduce the number of disease days of the child patient and shorten the time for reducing the body temperature of the child patient to normal, does not have adverse events, and has a good clinical application prospect. The traditional Chinese medicine composition has obvious curative effects on reducing fever and body temperature of the pneumonia dyspnea and cough phlegm-heat closed lung syndrome and relieving clinical symptoms, and can be used for treating the infantile pneumonia dyspnea and cough phlegm-heat closed lung syndrome.
Owner:贵州中医药大学第二附属医院

Preparation method of traditional Chinese medicine composition for treating pulmonary abscess

The invention relates to a preparation method of a traditional Chinese medicine composition for treating pulmonary abscess, which can effectively solve the problem of medication for treating pulmonary abscess. The oral liquid is prepared from the following raw material medicines: fresh rehmannia, fresh houttuynia cordata, fresh scutellaria baicalensis, fresh ginseng and gecko, and is prepared by cleaning, slicing, water adding, wall breaking, filtering, centrifuging, ultrafiltration, concentrating, freeze-drying, crushing, sieving, uniform mixing, vacuum packaging and sterilizing. The traditional Chinese medicine composition is prepared through a specific method according to the main and secondary relation of monarch, minister, assistant and guide, plays a synergistic effect, has the effects of clearing away lung-heat and detoxifying, dispersing blood stasis and eliminating carbuncle, strengthening the body resistance to eliminate pathogenic factors, and removing stasis and dredging collaterals, can be effectively used for treating pulmonary abscess, is simple in preparation method, convenient to operate, safe and environment-friendly, can keep active ingredients in the traditional Chinese medicines to the greatest extent, and has a remarkable curative effect on treating pulmonary abscess. The traditional Chinese medicine composition is free of toxic and side effects, has very good practical clinical application value and development and application prospects, and has huge economic and social benefits.
Owner:HENAN UNIV OF CHINESE MEDICINE

Medical disposable lung abscess interventional puncture negative pressure drainage device

The utility model belongs to the field of negative pressure drainage apparatuses, particularly relates to a medical disposable negative pressure drainage apparatus for lung abscess interventional puncture, and aims to solve the problems that an existing negative pressure drainage apparatus for lung abscess interventional puncture is high in material consumption, high in manufacturing cost and inconvenient to take and place due to the fact that the existing negative pressure drainage apparatus cannot be supported in shape when in use, and comprises a top cover, a containing bag and a bottom plate. An air suction vertical pipe is arranged at the top of the top cover, an injection connecting pipe is arranged at the top of the top cover, a liquid outlet valve is arranged on one side of the bottom of the containing bag, supporting rods are arranged on the two sides of the containing bag, the two supporting rods are supported between the top cover and the bottom plate, and scale marks are arranged on the sides, away from each other, of the two supporting rods. The supporting rod can be folded and stored, the overall structure is compact and convenient to carry and store, the blocking quality can be guaranteed through the design of the arc-shaped angle of the floating block, and therefore the overall structural design is more reasonable, all parts are connected more tightly, and operation is easier.
Owner:XINJIANG PROD & CONSTR CORPS HOSPITAL (SECOND AFFILIATED HOSPITAL OF SHIHEZI UNIV MEDICAL COLLEGE)

Therapeutic agent for inhalation pneumonia, pulmonary suppuration or pulmonary abscess

The present invention is a therapeutic agent for inhalation pneumonia, pulmonary suppuration or pulmonary abscess. [Problem] The present invention relates to a safer and more effective therapeutic agent for respiratory tract infections. [Solution] A therapeutic agent for inhalation pneumonia, pulmonary suppuration or pulmonary abscess, said agent containing, as an active ingredient, 7-[(3S, 4S)-3-{(cyclopropylamino) methyl}-4-fluoropyrrolidin-1-yl]-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid or a pharmaceutically acceptable salt thereof.
Owner:KYORIN PHARMACEUTICAL CO LTD

Traditional Chinese medicine composition for clearing lung and relieving cough and preparation method thereof

The traditional Chinese medicine composition comprises an adhesive and further comprises the following raw materials in parts by weight: houttuynia cordata, platycodon grandiflorum, lonicerae flos, selfheal, folium mori, chrysanthemum, lophatherum gracile, the root of kudzu vine, reed rhizome, mint, raw liquorice and the adhesive. The method comprises the following steps: cleaning medicinal materials, removing dust and impurities on the surfaces of the medicinal materials, respectively drying the cleaned medicinal materials, crushing the dried medicinal materials into fine powder by using a crusher, screening the crushed powder by using a screen to ensure uniform fineness of the powder, and fully mixing and uniformly stirring the medicinal material powder according to a formula proportion to uniformly distribute the medicinal material components. Houttuynia cordata and platycodon grandiflorum are used as main medicines, the houttuynia cordata is cold in nature, can clear away heat and toxic materials, has a good curative effect on heat-toxic diseases and has an excellent effect on treating lung-heat symptoms such as pulmonary abscess, pus vomiting, phlegm-heat, dyspnea and cough and the like, and the platycodon grandiflorum is good at ventilating lung qi.
Owner:TIANSHENG PHARMA GROUP

Lactobacillus paracasei ATG-EI strain or composition comprising same for preventing or treating respiratory disease

ActiveUS12667598B2DiseaseWhite blood cell
A novel strain, Lactobacillus paracasei ATG-E1 (Accession No. KCTC 14245BP), and a composition containing the same for preventing or treating respiratory diseases which are caused by fine particulate matter. The Lactobacillus paracasei ATG-E1 strain reduces the number of immune cells bronchoalveolar and lung tissues and inhibits the expression of inflammatory cytokines such as interleukin-17A (IL-17A), tumor necrosis factor-α (TNF-α), macrophage inflammatory protein 2 (MIP2), C-X-C motif chemokine ligand 1 (CXCL-1), macrophage inflammatory protein-α (MIP-1α) or interleukin-6 (IL-6). Therefore, the Lactobacillus paracasei ATG-E1 strain can be used for a treatment or health functional food for various respiratory diseases such as acute and chronic bronchitis, catarrhal bronchitis, bronchitis obliterans, inflammatory bronchitis, bronchial asthma, atopic asthma, non-atopic asthma, atopic IgE-mediated asthma, allergic asthma, non-allergic asthma, chronic bronchoconstriction, acute bronchoconstriction, chronic obstructive pulmonary disease, bronchial adenoma, pulmonary tuberculosis, emphysema, lung abscess, pulmonary fibrosis, lung cancer, airway cancer, bronchoalveolar cancer, and bronchial cancer.
Owner:ATOGEN CO LTD +1